BiotechTubeBiotechTube
Glycomine

Glycomine

Phase 2
San Mateo, United StatesFounded 2015glycomine.com

We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.

Founded
2015
Focus
Small Molecules

About

We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.

Funding History

2

Total raised: $38M

Series A$33MSanderling VenturesJan 15, 2020
Seed$5MUndisclosedJun 15, 2017

Company Info

TypePrivate
Founded2015
LocationSan Mateo, United States
StagePhase 2

Contact

glycomine.com

Sectors

Small Molecule DrugsRare & Orphan Diseases
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile